PDN
CRL icon

Pensionfund DSM Netherlands’s Charles River Laboratories CRL Stock Holding History

Pensionfund DSM Netherlands’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-800
Closed -$301K – 158
2021
Q4 		$301K Hold
800
– – 0.03% 438
2021
Q3 		$330K Buy
+800
New +$332K 0.04% 440

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pensionfund DSM Netherlands's CRL Position: Q1 2022 in Review

Pensionfund DSM Netherlands sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 800 shares — an estimated $301K sold.

Pensionfund DSM Netherlands first reported a position in CRL in Q3 2021 and held it in 2 quarters. The position peaked at $330K in Q3 2021. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • Pensionfund DSM Netherlands reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • Pensionfund DSM Netherlands sold 800 Charles River Laboratories shares in Q1 2022, an estimated $301K.
  • Pensionfund DSM Netherlands first reported a position in Charles River Laboratories in Q3 2021 and held it in 2 quarters.
  • Pensionfund DSM Netherlands's Charles River Laboratories position peaked at $330K in Q3 2021.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on Pensionfund DSM Netherlands's 13F filing for Q1 2022, filed 12 Apr 2022.